Executives from Frost & Sullivan have been invited to serve as judges for the 2022 BSA Future Stars Awards and attend the award ceremony

Executives from Frost & Sullivan have been invited to serve as judges for the 2022 BSA Future Stars Awards and attend the award ceremony

2022/08/10

August 8, 2022, HVIS The 2nd China International Vaccine Innovation Summit 2022 grandly opened in Beijing on the 9th. On the same day, the results of the [BSA Future Star Award Selection], initiated and hosted by the 2nd China International Vaccine Innovation Summit, were announced. The 2022 BSA Future Star Awards Ceremony was held with great pomp.  Frost & Sullivanfrost &Mr. Mao Hua, Partner and Managing Director of Frost & Sullivan's Greater China Region, was invited to serve as an industry expert reviewer, attended the award ceremony as an award-giving guest, and presented awards to the winner of the 'BSA Future Star First Prize', Zhejiang Haichang Biomedical Technology Co., Ltd. 

Mr. Mao Huaing presented awards to Zhejiang Haichang Biomedical Technology Co., Ltd.

Group photo of award-winning enterprises and awarding guests

 

Best StartupThe Awards (BSA) is a startup competition focused on the vaccine industry, initiated by the BoMaiSi & International Vaccine Innovation Summit in 2021 and open to the whole country. The BSA brings together the most authoritative experts, vaccine business dark horses, industry leaders, and senior media figures. It tracks and studies numerous startup cases in the vaccine industry field, conducts in-depth analysis, and emphasizes scientifically defining aspects such as business models, teams, technological trends, and investment potential in the vaccine sector. It establishes a framework evaluation system for start-up enterprises in the vaccine industry, comprehensively assessing the innovation capabilities, business models, teams, technical abilities, and development prospects of Chinese vaccine enterprises. The BSA aims to promote the best 'entrepreneurial innovation' model of Chinese vaccine startups, drive commercial innovation and scientific research achievement transformation of Chinese vaccine enterprises, and provide highly valuable investment guidance for domestic and international investors.

 

A total ofThe registration form for 33 companies, along with an online vote of approximately 800,000, received widespread attention from all sectors of society. Ultimately, after fierce competition among the ten shortlisted companies, the jury scored them based on eight dimensions: technology, model, solution, prospects, capital, profit model, resources and capabilities, as well as customer value proposition. The top three companies in terms of score ultimately won the [BSA Future Star Award], while the company that received the highest number of votes among the participating companies was awarded the [BSA Most Popular Company Award].

List of winners 

[Star of the Future, First Place]

 Zhejiang Haichang Biomedical Technology Co., Ltd. 

 

[Star of the Future, 2nd Place]

 Shanghai Herui Biomedical Technology Co., Ltd. 

 

[Star of the Future, 3rd Place]

 Hangzhou Jietai Pharmaceutical Technology Co., Ltd. 

 

[Most Popular Enterprise Award]

 Zhuhai Lifanda Biotechnology Co., Ltd. 


联系我们
联系我们
电话

业务咨询热线

(021)54075836

微信
二维码

扫码关注官方微信公众号

返回顶部
返回顶部

联系我们

×
请选择职位类别
请选择
×